234 related articles for article (PubMed ID: 16946501)
1. Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells.
Liu YQ; Mu ZQ; You S; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2006 Sep; 29(9):1873-9. PubMed ID: 16946501
[TBL] [Abstract][Full Text] [Related]
2. Activation of phosphoinositide 3-kinase, protein kinase C, and extracellular signal-regulated kinase is required for oridonin-enhanced phagocytosis of apoptotic bodies in human macrophage-like U937 cells.
Liu YQ; You S; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2005 Aug; 98(4):361-71. PubMed ID: 16079470
[TBL] [Abstract][Full Text] [Related]
3. ROS-mediated p38alpha MAPK activation and ERK inactivation responsible for upregulation of Fas and FasL and autocrine Fas-mediated cell death in Taiwan cobra phospholipase A(2)-treated U937 cells.
Liu WH; Cheng YC; Chang LS
J Cell Physiol; 2009 Jun; 219(3):642-51. PubMed ID: 19180563
[TBL] [Abstract][Full Text] [Related]
4. [Oridonin induced U937 cell apoptosis through ERK pathway].
Liu YQ; You S; Tashiro S; Onodera S; Ikejima T
Zhongguo Zhong Yao Za Zhi; 2005 Dec; 30(23):1856-9. PubMed ID: 16499027
[TBL] [Abstract][Full Text] [Related]
5. Mitogen-activated protein kinase/extracellular signal-regulated kinase signaling in activated T cells abrogates TRAIL-induced apoptosis upstream of the mitochondrial amplification loop and caspase-8.
Söderström TS; Poukkula M; Holmström TH; Heiskanen KM; Eriksson JE
J Immunol; 2002 Sep; 169(6):2851-60. PubMed ID: 12218097
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome c release from oridonin-treated apoptotic A375-S2 cells is dependent on p53 and extracellular signal-regulated kinase activation.
Zhang CL; Wu LJ; Zuo HJ; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2004 Oct; 96(2):155-63. PubMed ID: 15492467
[TBL] [Abstract][Full Text] [Related]
7. Roles of Ras and extracellular signal-regulated kinase-dependent IkappaBalpha degradation in oridonin-enhanced phagocytosis of apoptotic cells by human macrophage-like U937 cells.
Liu YQ; You S; Tashiro S; Onodera S; Ikejima T
Int Immunopharmacol; 2006 Feb; 6(2):260-8. PubMed ID: 16399631
[TBL] [Abstract][Full Text] [Related]
8. Oridonin induces a caspase-independent but mitochondria- and MAPK-dependent cell death in the murine fibrosarcoma cell line L929.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
Biol Pharm Bull; 2004 Oct; 27(10):1527-31. PubMed ID: 15467189
[TBL] [Abstract][Full Text] [Related]
9. A comparison of the signal pathways between the TNF alpha- and oridonin-induced murine L929 fibrosarcoma cell death.
Huang J; Wu L; Tashiro S; Onodera S; Ikejima T
Acta Med Okayama; 2005 Dec; 59(6):261-70. PubMed ID: 16418769
[TBL] [Abstract][Full Text] [Related]
10. Fas drives cell cycle progression in glioma cells via extracellular signal-regulated kinase activation.
Shinohara H; Yagita H; Ikawa Y; Oyaizu N
Cancer Res; 2000 Mar; 60(6):1766-72. PubMed ID: 10749152
[TBL] [Abstract][Full Text] [Related]
11. Antitumor triptycene bisquinones induce a caspase-independent release of mitochondrial cytochrome c and a caspase-2-mediated activation of initiator caspase-8 and -9 in HL-60 cells by a mechanism which does not involve Fas signaling.
Perchellet EM; Wang Y; Weber RL; Lou K; Hua DH; Perchellet JP
Anticancer Drugs; 2004 Nov; 15(10):929-46. PubMed ID: 15514562
[TBL] [Abstract][Full Text] [Related]
12. Zeta-associated protein of 70 kDa (ZAP-70), but not Syk, tyrosine kinase can mediate apoptosis of T cells through the Fas/Fas ligand, caspase-8 and caspase-3 pathways.
Zhong L; Wu CH; Lee WH; Liu CP
J Immunol; 2004 Feb; 172(3):1472-82. PubMed ID: 14734724
[TBL] [Abstract][Full Text] [Related]
13. Arachidonic acid induces Fas and FasL upregulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/ATF-2 pathway.
Liu WH; Chang LS
Toxicol Lett; 2009 Dec; 191(2-3):140-8. PubMed ID: 19720122
[TBL] [Abstract][Full Text] [Related]
14. Synthetic 1,4-anthracenedione analogs induce cytochrome c release, caspase-9, -3, and -8 activities, poly(ADP-ribose) polymerase-1 cleavage and internucleosomal DNA fragmentation in HL-60 cells by a mechanism which involves caspase-2 activation but not Fas signaling.
Perchellet EM; Wang Y; Weber RL; Sperfslage BJ; Lou K; Crossland J; Hua DH; Perchellet JP
Biochem Pharmacol; 2004 Feb; 67(3):523-37. PubMed ID: 15037204
[TBL] [Abstract][Full Text] [Related]
15. Oridonin induced A375-S2 cell apoptosis via bax-regulated caspase pathway activation, dependent on the cytochrome c/caspase-9 apoptosome.
Zhang CL; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Asian Nat Prod Res; 2004 Jun; 6(2):127-38. PubMed ID: 15008459
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of c-Met promoted apoptosis, autophagy and loss of the mitochondrial transmembrane potential in oridonin-induced A549 lung cancer cells.
Liu Y; Liu JH; Chai K; Tashiro S; Onodera S; Ikejima T
J Pharm Pharmacol; 2013 Nov; 65(11):1622-42. PubMed ID: 24102522
[TBL] [Abstract][Full Text] [Related]
17. Oridonin-induced A431 cell apoptosis partially through blockage of the Ras/Raf/ERK signal pathway.
Li D; Wu LJ; Tashiro S; Onodera S; Ikejima T
J Pharmacol Sci; 2007 Jan; 103(1):56-66. PubMed ID: 17251686
[TBL] [Abstract][Full Text] [Related]
18. Activation of caspase-8 in drug-induced apoptosis of B-lymphoid cells is independent of CD95/Fas receptor-ligand interaction and occurs downstream of caspase-3.
Wieder T; Essmann F; Prokop A; Schmelz K; Schulze-Osthoff K; Beyaert R; Dörken B; Daniel PT
Blood; 2001 Mar; 97(5):1378-87. PubMed ID: 11222383
[TBL] [Abstract][Full Text] [Related]
19. Stimulation of Fas/FasL-mediated apoptosis by luteolin through enhancement of histone H3 acetylation and c-Jun activation in HL-60 leukemia cells.
Wang SW; Chen YR; Chow JM; Chien MH; Yang SF; Wen YC; Lee WJ; Tseng TH
Mol Carcinog; 2018 Jul; 57(7):866-877. PubMed ID: 29566277
[TBL] [Abstract][Full Text] [Related]
20. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
Lu B; Wang L; Stehlik C; Medan D; Huang C; Hu S; Chen F; Shi X; Rojanasakul Y
J Immunol; 2006 Jun; 176(11):6785-93. PubMed ID: 16709838
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
